Zenith Epigenetics Corp. announced that it has appointed Joy Zhu as Chief Medical Officer, Sanjay Lakhotia as Chief Business Officer, and Michael Yakes as Vice President Drug Discovery and Exploratory Development. Prior to joining Zenith, Dr. Zhu held leadership positions at SUGEN/Pfizer, SBIO Pte Ltd, Amgen, JNJ, and Novartis.

Most recently, Dr. Zhu led oncology clinical development at Halozyme Therapeutics.